NDC 73352-090 – Zanaflex
Tizanidine Hydrochloride 8 mg/1 · Capsule · Oral
Product NDC73352-090
Product details
- Brand name
- Zanaflex
- Generic name
- Tizanidine hydrochloride
- Labeler
- Trifluent Pharma, LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA213798
- Marketed since
- September 16, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Active ingredients
- Tizanidine Hydrochloride 8 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 73352-090-60 | 60 CAPSULE in 1 BOTTLE (73352-090-60) | Sep 16, 2025 |
Other Zanaflex products
- 70515-602 Tizanidine Hydrochloride 2 mg/1 · Capsule · Covis Pharma US, Inc
- 70515-604 Tizanidine Hydrochloride 4 mg/1 · Capsule · Covis Pharma US, Inc
- 70515-606 Tizanidine Hydrochloride 6 mg/1 · Capsule · Covis Pharma US, Inc
- 83107-001 Tizanidine Hydrochloride 2 mg/1 · Capsule · Legacy Pharma USA, Inc.
- 83107-002 Tizanidine Hydrochloride 4 mg/1 · Capsule · Legacy Pharma USA, Inc.
- 83107-003 Tizanidine Hydrochloride 6 mg/1 · Capsule · Legacy Pharma USA, Inc.
- 70515-594 Tizanidine Hydrochloride 4 mg/1 · Tablet · Covis Pharma US, Inc
- 83107-004 Tizanidine Hydrochloride 4 mg/1 · Tablet · Legacy Pharma USA, Inc.